Neil Hunn
President and Chief Executive Officer at Roper Technologies
Thanks Rob. Let's turn to page 11 and walk through our 3Q highlights for our application software segment. Revenues here were $644 million, up 7% on an organic basis, and EBITDA margins were 43.6%. Across this segment, we saw recurring revenue which is about 75% of the revenue for this segment, increased 8% in the quarter. This recurring revenue growth was enabled by strong customer retention and continued migration to our SaaS delivery models. Across this group of companies, the financial strength was broad and has been quite consistent for several quarters running.
As we highlight a few businesses, we will start with Vertafore, who had another great quarter bookings growth, revenue growth and margin performance. Vertafore continues to see success in their software solutions targeted to the P&C insurance market, with particular strength in the enterprise-class market segment. Across both Deltek and Aderant, we continued to see solid new customer adds and nice momentum and migration towards our SaaS solutions. Also, in the quarter we acquired [Indecipherable] technologies for Deltek, a leading software provider servicing the GovCon Manufacturing and QA market and VI Global for Aderant, a leading human resources and recruiting software tool for global law firms.
CBORD, our Nutrition and Access Management software business had strength across both education and healthcare end markets. CliniSys and Data Innovation continued to exhibit strong demand and operational strength. CliniSys continued its market share gains across Europe, and DI continues to demonstrate product market fit by gaining share of wallet across large healthcare systems. Strata continues to be solid for us as evidenced by strong new customer adds, cross-selling and renewal activity. Finally, Frontline will be reported in this segment starting in Q4. Looking at the outlook for the final quarter of the year, we expect to see organic growth in the 6% to 8% area.
Turning to page 12, revenues in the quarter for our network software segment were $347 million, up 10% on organic basis and EBITDA margins were strong at 54.5%. The 10% organic growth in this segment is underpinned by 16% growth in recurring revenue.
As we dig into business-specific performance, our U.S. and Canadian freight matching businesses continue to be fantastic. The market conditions while slowing a touch on the carrier side of the network, remained favorable. These businesses saw a nice new customer adds and ARPU increases during the quarter.
Moving to foundry, our software business that enables live-action filming and computer-generated graphics to be combined in a single frame, again demonstrated our financial strength. Net retention was very strong and ARR grew in the strong double digits again. Foundry success is rooted in their fast-paced innovation capability and favorable long-term market conditions.
Growth in our businesses that focus on alternate site healthcare was led by SHP and SoftWriters, and importantly retention rates across each of these businesses remained extremely high.
Finally, iTrade, our network food supply-chain business and iPipeline, our life insurance SaaS business that tech enables the quoting and underwriting processes, each has solid customer additions which helped drive strong ARR growth in the quarter.
Turning to the outlook for the fourth quarter, we expect to see 8% to 10% organic growth for this segment.
As we turn to page 13, revenues in our tech-enabled product segment were $360 million, up 15% on organic basis. EBITDA margins for the segment increased nicely to 37.2% in the quarter. It's very nice to see 15% organic growth in the quarter and easing supply-chain challenges. While supply-chain challenges remained, we experienced demonstrable easing conditions especially as it relates to chips and chipsets. We are cautiously optimistic, conditions will continue to improve.
Let's start with Neptune, which once again set records for orders and quarter-end backlog. For a few quarters running, Neptune was able to gain market share by successfully maintaining industry-leading product lead times, while simultaneously launching new products, both in terms of cellular connectivity and static meter reading technologies. To this end, Neptune continues to experience accelerating demand for their static meter solutions.
Verathon was simply strong. They grew nicely in the quarter driven by momentum across all three components of the product portfolio; bladder volume measurement, video innovation and single-use bronchoscopes. As it relates to the Northern Digital, they set a new record for quarterly revenues as we experienced continued strong demand for their precision measurement solutions.
Our outlook for the final quarter of the year is 5% to 7% organic growth for this segment as we have a more difficult comp heading into Q4.
Now please turn to page 15, and let's review our updated and increased outlook for the balance of the year. As a reminder, last quarter we increased our adjusted DEPS outlook to be between $13.46 and $13 62. We are now once again increasing our guidance to be between $14.09 and $14.13, an increase of $0.57 at the midpoint. This increase in guidance is driven by a strong third quarter performance and the momentum we carry into Q4, together with the addition of Frontline Education.
Embedded in this guidance is full-year organic growth of 9% plus, an increase from 8% to 9% organic growth guidance discussed last quarter. As we look to the fourth quarter, we're establishing DEPS guidance to be in the range of $3.72 and $3.76.
Now our concluding comments, and we'll get to your questions.
As we turn to page 16, we want to leave you with the same key points with which we started. First, we had another great quarter of operational and financial performance, and we are increasing our outlook for the year. Second, we acquired another leading net software business Frontline Education. Third, we continue to have substantial M&A firepower north of $4 billion. And fourth and perhaps the most important, the new higher-quality Roper portfolio is becoming ever more visible. As it relates to our strong start, we grew revenues organically by 10% and EBITDA by 12%. We're lifting our full-year organic growth and depth guidance based on the factors previously discussed.
Regarding capital deployment, we have been active. Over the past couple of months, we deployed just over $4 billion. To this end, our prudence and patience are being rewarded for the identification of selection of these high-quality assets. We continue to have a large amount of available M&A capacity north of $4 billion. We continue to be very active in the M&A markets, but as you saw in Q3, as always, we remain super patient and highly disciplined to ensure optimal deployment of our available capital.
Finally, and perhaps the most important, the new higher-quality Roper portfolio is becoming increasingly more evident, and we have never been more excited about the future of [Indecipherable]
As we turn to your questions, let us remind everyone that our strategy is the same. We compound cash-flow by acquiring and growing niche market-leading technology businesses. This is what we've done for over 20 years and we'll continue to do. In addition, our value-creation and governance model remains unchanged. We operate a portfolio of market-leading businesses and defensible niches. Each of our businesses has high levels of recurring revenue, strong margins and competes based on customer intimacy, which yield highly resilient organic growth rates. We operate in highly decentralized operating structure that focuses on long-term business building. Our culture sets a very high bar for performance and focus is on continually improving. We are all paid to grow, which reinforces our culture of transparency, nimbleness and humility. Finally, we redeploy the vast majority of our capital to acquire the next great business. We do this with centralized corporate resources in a highly disciplined, thoughtful and analytical manner. This strategy unchanged delivers compounded and superior long-term shareholder value.
So, thanks for joining us this morning, and with that, let's open up to your questions.